International Congress London 2016

Saturday, 03.09.2016 Sunday, 04.09.2016 Monday, 05.09.2016 Tuesday, 06.09.2016 Wednesday, 07.09.2016		Sponsored symposia: Industry Evening Mini Symposium at ERS 2016: “Challenges in the management of non-CF bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2016; 48: Suppl. 60, abstract number.

The stage I non-small-cell lung cancer

Symposium
Chairs: Dragan R. Subotic (Belgrade, Republic of Serbia), Nicolas Schönfeld (Berlin, Germany)
Aims: This session aims to provide a comprehensive and updated overview of issues related to early stage lung cancer that are still being debated. These issues include the optimal diagnostics, the benefits of molecular diagnostics and biomarkers, the factors that influence the treatment outcome, and the rapidly changing spectrum of surgical options for stage I NSCLC.

Download all media

Biological markers Virginie Westeel (Besançon, France)
Role of CT and PET in detecting non-aggressive stage IA NSCLC Walter De Wever (Leuven, Belgium)
Wide therapeutic spectrum for limited disease: lobectomy vs. segmentectomy, and video-assisted thoracoscopic surgery (VATS) vs. open surgery Martin Hürtgen (Koblenz, Germany)
Survival predictors Paul E. Van Schil (Edegem (Antwerp), Belgium)